3rd ESHG Training Course on Pharmacogenomics - Manchester Rare Conditions Centre 📍 Date: Wednesday 11 – Friday 13 November 2026 🌎 Location: Renold Building, Sister, 32a Altrincham St, Manchester M1 7JR, UK 🧬 Format: In-Person | Duration: 3 Days

📢 Register now!

Join the 3rd ESHG Training Course on Pharmacogenomics
📅 11–13 November 2026
📍 Manchester, UK

🧬3-day in-person course on how pharmacogenomics can be applied in clinical practice

🔗 Programme & registration: www.mrcc.org.uk/events/eshg-...

#ESHG #Genetics #Genomes #Pharmacogenomics

The goal of #pharmacogenomics is to improve patient outcomes by tailoring drug therapies to an individual’s genetic makeup🧬💊. #Bioinformatics supports this vital research in various ways, find out more at www.fiosgenomics.com/pharmacogenomics-and-bio...
#personalisedmedicine

Genomics implementation in practice: opportunities, progress and challenges Genomics is now an established area of the NHS, rather than a purely aspirational idea. In England, the NHS Genomic Medicine Service (GMS) — established in 2018 — has been tasked with implementing…

In this blog article, #AdrushaRamsunder and #RachelPalmer explore what progress has been made towards a genomics population health service, what challenges need to be overcome and what is the role of pharmacy?

#ukpharmacy #pharmacogenomics

Innovative Genetic Testing Service 'Genovision PGx' Set to Transform Personalized Medicine NTT Precision Medicine is launching 'Genovision PGx', a genetic testing service aimed at personalizing treatment options based on drug response and side effects.

Innovative Genetic Testing Service 'Genovision PGx' Set to Transform Personalized Medicine #Japan #Tokyo #Precision_Medicine #pharmacogenomics #Genovision_PGx

Why do ~35–61% of people with #ADHD stop their medication within a year? 🛑💊🧠

Read the full paper here: 🔓 www.nature.com/articles/s41...

#pharmacogenomics

It’s National Adverse Drug Event Awareness Day! ADEs are the 3rd leading cause of death in the US, but this can change w/ #PGx testing. Join ACMG on 4/21/26 to hear more about #pharmacogenomics implementation strategies. Register at tinyurl.com/2tv5j58s. #ThirdCause #MedSafety

The goal of #pharmacogenomics is to improve patient outcomes by tailoring drug therapies to an individual’s genetic makeup🧬💊. #Bioinformatics supports this vital research in various ways, find out more at www.fiosgenomics.com/pharmacogenomics-and-bio...
#personalisedmedicine

In our #TalkingMeds #podcast launching tomorrow, Jonathan Underhill is joined by Vicky Chaplin and Paul Selby for part 2 on 'Genomics-informed medicines optimisation'.

Listen on your usual podcast platform! 🎧

Find out more: https://ow.ly/fsk950Y8Er0

#pharmacogenomics

RPS publishes pharmacogenomics prescribing resource for all prescribers The Royal Pharmaceutical Society (RPS) has published a pharmacogenomics resource — supported by NHS England — which offers support for prescribers in any healthcare discipline to expand their…

The Royal Pharmaceutical Society has published a pharmacogenomics resource — supported by NHS England — which offers support for prescribers in any healthcare discipline to expand their competence and improve patient outcomes

#ukpharmacy #pharmacogenomics #prescribing

Meet TC3 Member Prof. Rachel Tyndale! Her work focuses on pharmacogenomics and pharmacokinetics of substance use disorders.
#cannabis #endocannabinoid #pharmacogenomics #pharmacokinetics #cannabisusedisorder #CUD

@utoronto.ca @camhnews.bsky.social

UK Clinical Pharmacy Association launches pharmacogenomics guidance Pharmacists, GPs and nurse prescribers have access to a free, searchable online resource to help them tailor medicines to patients’ genetic profiles at the point of care, following the launch of the…

The UK Clinical Pharmacy Association has launched pharmacogenomics guidance aimed to offer pharmacists, GPs and nurse practitioners access to online evidence-based advice and guidance in one place

#UKCPA #pharmacogenomics #PGx #genomicmedicine #primarycare

buff.ly/UhSoAnL

Understanding DPYD Testing: From Guidelines to Implementation in the Laboratory Join the upcoming webinar on DPYD testing and learn about effective implementation from guidelines to practical usage. Enhance your pharmacogenomics practices!

Understanding DPYD Testing: From Guidelines to Implementation in the Laboratory #Canada #Toronto #Webinar #pharmacogenomics #DPYD_Testing

Fluoropyrimidines remain essential in oncology, but patient safety depends on an accurate assessment of DPYD metabolism. Discover how NGS-based #pharmacogenomics revealed genetic variability in a 1,145-patient study and supported safer treatment decisions.
Register: hubs.la/Q045ky8k0 #sequencing

The goal of #pharmacogenomics is to improve patient outcomes by tailoring drug therapies to an individual’s genetic makeup🧬💊. #Bioinformatics supports this vital research in various ways, find out more at www.fiosgenomics.com/pharmacogenomics-and-bio...
#personalisedmedicine

Curious about drug discovery or pharmacogenomics? You need to see this...

#DeepTarget (new on #Bioconductor3.22) helps you:

💡 Predict targets
⚡ Rank hits
🧪 Cut lab tests

Thanks to: Sanju Sinha, Trinh Nguyen & Ying Hu

@bioconductor.bsky.social

#Bioconductor #DrugDiscovery #Pharmacogenomics

✨ A new star allele was born! Excited to share our first in vivo pharmacokinetic recall study involving 114 participants from @ESTbiobank with previously uncharacterised variants in CYP2C19 and CYP2D6:
www.nature.com/articles/s41... #Pharmacogenomics @pharmvar.org @clinpgx.org

Was a Canadian baby poisoned by breast milk? Experts say no. Yet a 20-year-old case study remains influential | CBC News A controversial Canadian medical paper, which pinned a baby’s death on codeine passed through breastmilk, is under renewed scrutiny a full two decades after it was published. The paper sparked a sweep...

Huh. This story was a common driver of #pharmacogenomics research.
www.cbc.ca/news/health/...

Episode 48: Our UK Team Advancing Pharmacogenomics in Healthcare In Episode 48 of the Informonster Podcast, Charlie Harp is joined by Clinical Architecture’s UK team members Chris Gray and Alex Wren to explore how pharmacogenomics is moving from research into…

🎙️ New Informonster Podcast! How is #pharmacogenomics moving from research into real-world care?
Chris Gray & Alex Wren from our UK team share how the NHS Progress Project is embedding genetic insights into clinical workflows for safer prescribing at scale.

🎧

The goal of #pharmacogenomics is to improve patient outcomes by tailoring drug therapies to an individual’s genetic makeup🧬💊. #Bioinformatics supports this vital research in various ways, find out more at www.fiosgenomics.com/pharmacogenomics-and-bio...
#personalisedmedicine

Don't miss #TalkingMeds podcast tomorrow. In the 1st of 2 episodes on #pharmacogenomics, Jonathan Underhill, Vicky Chaplin & Paul Selby introduce the concept of genomics-informed medicines optimisation, & discuss progress at a national and local level in the NHS.

Listen on your usual platform!

Expert Review

Exploring the Genetic Landscape of Psoriatic Arthritis: A Narrative Review of Recent Genomic Studies

📖 doi.org/10.3899/jrhe...
@usherbrooke.bsky.social

#Genomics #Pharmacogenomics #PsoriaticArthritis

VirTarget: Virus-Informed Pharmacogenomics Framework Identifies Immunotherapies That Mitigate Epstein–Barr Virus–Driven Dysregulation in Multiple Sclerosis Background Epstein–Barr virus (EBV) is increasingly recognized as a central driver of multiple sclerosis (MS), yet current immunotherapies are selected without regard to their effects on EBV or EBV–MS genetic interactions. To address this gap, we developed VirTarget , the first virus-informed ph...

VirTarget, a virus-informed pharmacogenomics framework, identifies immunotherapies mitigating Epstein-Barr virus-driven dysregulation in multiple sclerosis, enabling precision treatment strategies. #EBV #Pharmacogenomics #MS
📄 https://doi.org/10.1101/2025.11.03.686445 
👤 EVBC member: Anna Onisiforou

Matters of the heart: A pharmacogenomics (PGx) success story Discover how personalized medicine and pharmacogenomics testing helped Army Veteran Dariton Robinson manage his high cholesterol with fewer side effects.

Linking Pharmacogenomics and Pharmacovigilance Data to Solve Drug-induced Problems Pharmacovigilance has come a long way in helping us link medicines to their side-effects; with the help of pharmacogenomics it can go even further.

We may be nearing the end of 2025, but we're just starting our countdown of the 🔝top 5 #UppsalaReports articles of the past year.

In the number 5️⃣ spot, we explore how #pharmacogenomics and #pharmacovigilance data can help address drug-induced problems:

Health news round-up: haematology, mental health and pharmacogenomics Following the appointments of four pharmacists and pharmacy technicians as new Scottish pharmacy clinical leadership fellows, the General Pharmaceutical Council (GPhC) announced this week that Niketa…

*Health news round-up: #haematology, #mentalhealth and #pharmacogenomics*

A weekly summary of important developments in health news that you may have missed

RPS launching new pharmacogenomic resource for all prescribers The RPS is launching a resource to help prescribers develop their pharmacogenomic competence and standardise pharmacogenomic education.

RPS launching new pharmacogenomic resource for all prescribers

buff.ly/99VLZOz

#RPS #pharmacy #UKpharmacy #pharmacogenomics #prescribers #genomics

The impact of asparaginase phenotype-related single nucleotide polymorphisms on prognosis in pediatric B-cell precursor acute lymphoblastic leukemia.
Liu, Lixia et al.
Paper
Details
#AcuteLymphoblasticLeukemia #Pharmacogenomics #PediatricOncology

All patients should undergo pharmacogenetic testing before being prescribed clopidogrel A UK-first guideline has recommended that all patients should have pharmacogenetic testing to identify clinically relevant CYP2C19 genetic variants, regardless of indication. The clinical guideline,…

A UK-first guideline has recommended that all patients should have pharmacogenetic testing to identify clinically relevant CYP2C19 genetic variants, regardless of indication

#ukpharmacy #pharmacogenomics #bloodclots

The goal of #pharmacogenomics is to improve patient outcomes by tailoring drug therapies to an individual’s genetic makeup🧬💊. #Bioinformatics supports this vital research in various ways, find out more at www.fiosgenomics.com/pharmacogenomics-and-bio...
#personalisedmedicine